SCHEMBL8417752

SCHEMBL8417752

CC(C)(C)Cc1ccc(N(C(=N)N)c2ccc(CC(C)(C)C)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.48
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
SLC6A2 P23975 2/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
HRH1 P35367 1/20 0.33
HTR2B P41595 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
BLM P54132 1/20 0.33
ESR2 Q92731 1/20 0.32
NOS1 P29475 1/20 0.32
IDO1 P14902 4/20 0.32
TAAR1 Q96RJ0 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11079638 0.79 IDO1 (0.52) IDO1TAAR1GRIN2DGRIN3BGRIN1
SCHEMBL8416776 0.75 SLC22A2 (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8224852 0.75 PRSS1 (0.57) ESR1THRATHRB
SCHEMBL8417727 0.73 CA2 (0.46) ESR1SLC6A2HTR2ASLC6A4SLC6A3
SCHEMBL6685103 0.72 ESR1 (0.74) ESR1THRATHRBSLC6A2HTR2A
SCHEMBL1754132 0.71 ALDH1A1 (0.58) ESR1THRATHRB
SCHEMBL158673 0.71 ALDH1A1 (0.44) IDO1
SCHEMBL12636017 0.70 ESR1 (0.48) ESR1THRATHRBGRIN2DGRIN3B
Hydrochloric Acid SCHEMBL5809829 0.70 IDO1 (0.44) IDO1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22139579 0.68 ESR1 (0.50) ESR1THRATHRBSLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0940139-A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1999-09-08 EP claimed
EP-0584088-A4 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS. CAMBRIDGE NEUROSCIENCE RES (US) 1995-01-18 EP claimed
EP-0584088-A1 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1994-03-02 EP claimed
WO-1992014697-A1 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1992-09-03 WO claimed
EP-0940139-A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1999-09-08 EP disclosed